Our group has focused on the heat shock protein produced by Mycobacterium leprae (hsp65) as a vaccine antigen against several pathologies including TB, leishmaniasis [26], diabetes, arthritis [3,4,27-29] and cancer. Here, HSPD1 is linked to leishmaniasis.